Staff:

  • Alison Scowcroft - Director of Strategic Programmes
  • Helen Reed - Contracts and Business Support Manager

You can contact any of the team on enquiries@cpgmhealthcare.co.uk


A message from the Chair

​CHL has continued to grow and develop in maturity and reputation in 2019-2020. CHL’s strategy, which was defined in 2018-19, has been embedded into the infrastructure in 2019-20. The strategy informed a workplan with 4 programmes - Collaborate, Innovate, Empower and Efficient. All new and existing work was reviewed to ensure congruence with these programmes and their aims, and this embedded strategic approach ensures all projects will deliver our strategy.

GMHSCP and other locality commissioners such as Rochdale Council & CCG and Manchester Health & Care Commissioning (MHCC) have been key stakeholders for CHL this year, with existing relationships cemented by the delivery of additional projects implemented to support pharmacy service delivery across GM. Examples include sexual health services transitioned to PharmOutcomes and Palliative Care. Feedback from commissioners around the work delivered by CHL and the relationships with its representatives has been exemplary and this continues to ensure that new contracts are secured, and existing agreements renewed.

The CHL team  have worked hard to ensure that the organisation has greater, more transparent financial scrutiny. This covers both financial performance and budgeting. This has led to a thorough review of income and expenditure, key stakeholder analysis and further rationalisation and focus on those projects which are most valuable to CHL. A renewed direction and focus on profitability and value will continue into 20-21.

Several projects have been delivered in the Innovate programme, which have put CHL and community pharmacies in GM firmly onto the radar of NHS England & Improvement. The delivery of the GP CPCS (formerly GP DMIRS) pilot in GM has been instrumental in informing national rollout of the advanced service due in late 2020 and CHL has been acknowledged by the NHSE/I project team as a key source of knowledge, feedback and expertise in pilot delivery.

As the financial year ended and the COVID-19 pandemic broke, CHL clearly demonstrated its place in the community pharmacy leadership of GM by delivering a number of initiatives vital to the support of community pharmacy during the pandemic.


Peter Marks
Chair 

Directors:

  • Peter Marks (Chair) - LPC
  • Aneet Kapoor - LPC
  • Louise Gatley - Non LPC
  • Varun Jaraith - Non LPC
  • Vacancy - Non LPC


​